-
1
-
-
34547747499
-
Cancer of the rectum
-
7th ed. DeVita VT, Hellman S and Rosenberg SA eds, Philadelphia, Lippincott, Williams and Wilkins, pp
-
Libretti S, Tepper J, Saltz L and Rustgi A: Cancer of the rectum. In: Principles and Practice of Oncology, 7th ed. DeVita VT, Hellman S and Rosenberg SA (eds.). Philadelphia, Lippincott, Williams and Wilkins, pp. 1118-1119, 2005.
-
(2005)
Principles and Practice of Oncology
, pp. 1118-1119
-
-
Libretti, S.1
Tepper, J.2
Saltz, L.3
Rustgi, A.4
-
2
-
-
0026632370
-
Combined modality therapy of rectal cancer: Decreased acute toxicity with the pre-operative approach
-
Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER and Frankel J: Combined modality therapy of rectal cancer: decreased acute toxicity with the pre-operative approach. J Clin Oncol 10: 1218-1224, 1992.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1218-1224
-
-
Minsky, B.D.1
Cohen, A.M.2
Kemeny, N.3
Enker, W.E.4
Kelsen, D.P.5
Reichman, B.6
Saltz, L.7
Sigurdson, E.R.8
Frankel, J.9
-
3
-
-
0032867918
-
Role of adjuvant therapy in adenocarcinoma of the rectum
-
Minsky BD: Role of adjuvant therapy in adenocarcinoma of the rectum. Semin Surg Oncol 17: 189-198, 1999.
-
(1999)
Semin Surg Oncol
, vol.17
, pp. 189-198
-
-
Minsky, B.D.1
-
4
-
-
0020393438
-
Pharmacologic requirements for obtaining sensitization of human tumor cells in vivo to combined 5FU and X-rays
-
Byfield J, Calabro P and Klisak I: Pharmacologic requirements for obtaining sensitization of human tumor cells in vivo to combined 5FU and X-rays. Int J Radiat Oncol Biol Phys 8: 1923-1933, 1982.
-
(1982)
Int J Radiat Oncol Biol Phys
, vol.8
, pp. 1923-1933
-
-
Byfield, J.1
Calabro, P.2
Klisak, I.3
-
5
-
-
0028136295
-
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
-
O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL and Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502-507, 1994.
-
(1994)
N Engl J Med
, vol.331
, pp. 502-507
-
-
O'Connell, M.J.1
Martenson, J.A.2
Wieand, H.S.3
Krook, J.E.4
Macdonald, J.S.5
Haller, D.G.6
Mayer, R.J.7
Gunderson, L.L.8
Rich, T.A.9
-
6
-
-
0032783898
-
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M.D. Anderson Cancer Center experience
-
Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA and Skibber J: Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44: 1027-1038, 1999.
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 1027-1038
-
-
Janjan, N.A.1
Khoo, V.S.2
Abbruzzese, J.3
Pazdur, R.4
Dubrow, R.5
Cleary, K.R.6
Allen, P.K.7
Lynch, P.M.8
Glober, G.9
Wolff, R.10
Rich, T.A.11
Skibber, J.12
-
7
-
-
0029681983
-
Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5- fluorouracil infusion and radiation therapy
-
Marsh RD, Chu NM, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C and Copeland EM: Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5- fluorouracil infusion and radiation therapy. Cancer 78: 217-225, 1996
-
(1996)
Cancer
, vol.78
, pp. 217-225
-
-
Marsh, R.D.1
Chu, N.M.2
Vauthey, J.N.3
Mendenhall, W.M.4
Lauwers, G.Y.5
Bewsher, C.6
Copeland, E.M.7
-
8
-
-
6044226542
-
German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Ischmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
Rodel, C.4
Wittekind, C.5
Fietkau, R.6
Martus, P.7
Ischmelitsch, J.8
Hager, E.9
Hess, C.F.10
Karstens, J.H.11
Liersch, T.12
Schmidberger, H.13
Raab, R.14
-
9
-
-
0031691506
-
Comparison of 5FU pharmacokinetics in patients receiving continuous 5FU and oral uracil, plus N15FU
-
Ho D, Pazdur R and Convington W: Comparison of 5FU pharmacokinetics in patients receiving continuous 5FU and oral uracil, plus N15FU. Clin Cancer Res 4: 2085-2088, 1998.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2085-2088
-
-
Ho, D.1
Pazdur, R.2
Convington, W.3
-
10
-
-
0036731818
-
Multicenter Phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
-
Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A and Benner SE: Multicenter Phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605-3616, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3605-3616
-
-
Douillard, J.Y.1
Hoff, P.M.2
Skillings, J.R.3
Eisenberg, P.4
Davidson, N.5
Harper, P.6
Vincent, M.D.7
Lembersky, B.C.8
Thompson, S.9
Maniero, A.10
Benner, S.E.11
-
11
-
-
0036727089
-
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
-
Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S and Martin C: Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617-3627, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3617-3627
-
-
Carmichael, J.1
Popiela, T.2
Radstone, D.3
Falk, S.4
Borner, M.5
Oza, A.6
Skovsgaard, T.7
Munier, S.8
Martin, C.9
-
12
-
-
5044220053
-
A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer
-
Pfeffer MR, Kundel Y, Zehavi M, Catane R, Koller M, Zmora O, Elkayam R and Symon Z: A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer. Isr Med Assoc J 6: 595-598, 2004.
-
(2004)
Isr Med Assoc J
, vol.6
, pp. 595-598
-
-
Pfeffer, M.R.1
Kundel, Y.2
Zehavi, M.3
Catane, R.4
Koller, M.5
Zmora, O.6
Elkayam, R.7
Symon, Z.8
-
13
-
-
34547733639
-
-
National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 3.0, June 10, 2003 update
-
National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 3.0, June 10, 2003 update.
-
-
-
-
14
-
-
0025325919
-
Infectious complications of indwelling long-term central venous catheters
-
Clark DE and Raffin TA: Infectious complications of indwelling long-term central venous catheters. Chest 97: 966-972, 1990.
-
(1990)
Chest
, vol.97
, pp. 966-972
-
-
Clark, D.E.1
Raffin, T.A.2
-
15
-
-
0033807408
-
Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan
-
Sadahiro S, Ohki S, Yamaguchi S, Takahashi T, Otani Y, Tsukikawa S, Yamamura T, Takemiya S, Nagasaki H, Nishiyama K, Fukushima T, Hiki Y, Yamaguchi S, Kumada K, Shimada H, Mitomi T and Makuuchi H: Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan. Cancer Chemother Pharmacol 46: 180-184, 2000.
-
(2000)
Cancer Chemother Pharmacol
, vol.46
, pp. 180-184
-
-
Sadahiro, S.1
Ohki, S.2
Yamaguchi, S.3
Takahashi, T.4
Otani, Y.5
Tsukikawa, S.6
Yamamura, T.7
Takemiya, S.8
Nagasaki, H.9
Nishiyama, K.10
Fukushima, T.11
Hiki, Y.12
Yamaguchi, S.13
Kumada, K.14
Shimada, H.15
Mitomi, T.16
Makuuchi, H.17
-
16
-
-
0041379123
-
Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer
-
Kim DJ, Kim TI, Suh JH, Cho YS, Shin SK, Kang JK, Kim AK and Kim WH: Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Yonsei Med J 44: 665-675, 2003.
-
(2003)
Yonsei Med J
, vol.44
, pp. 665-675
-
-
Kim, D.J.1
Kim, T.I.2
Suh, J.H.3
Cho, Y.S.4
Shin, S.K.5
Kang, J.K.6
Kim, A.K.7
Kim, W.H.8
-
17
-
-
6544280260
-
UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer
-
Smith R, Wickerham DL, Wieand HS, Colangelo L and Mamounas EP: UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer. Oncology (Hunting) 13(suppl 3): 44-47, 1999.
-
(1999)
Oncology (Hunting)
, vol.13
, Issue.SUPPL. 3
, pp. 44-47
-
-
Smith, R.1
Wickerham, D.L.2
Wieand, H.S.3
Colangelo, L.4
Mamounas, E.P.5
-
18
-
-
0036669123
-
Adjuvant therapy of resectable rectal cancer
-
Minsky BD: Adjuvant therapy of resectable rectal cancer. Cancer Treat Rev 28: 181-188, 2002.
-
(2002)
Cancer Treat Rev
, vol.28
, pp. 181-188
-
-
Minsky, B.D.1
-
19
-
-
0035985283
-
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy
-
Feliu J, Calvilio J, Escribano A, de Castro J, Sanchez ME, Mata A, Espinosa E, Garcia Grande A, Mateo A and Gonzalez Baron M: Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 13: 730-736, 2002.
-
(2002)
Ann Oncol
, vol.13
, pp. 730-736
-
-
Feliu, J.1
Calvilio, J.2
Escribano, A.3
de Castro, J.4
Sanchez, M.E.5
Mata, A.6
Espinosa, E.7
Garcia Grande, A.8
Mateo, A.9
Gonzalez Baron, M.10
-
20
-
-
18644380785
-
Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: Results from a phase II study
-
Uzcudun AE, Batlle JF, Velasco JC, Sanchez Santos ME, Carpeno Jde C, Grande AG, Juberias AM, Pineiro EH, Olivar LM and Garcia AG: Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Dis Colon Rectum 45: 1349-1358, 2002.
-
(2002)
Dis Colon Rectum
, vol.45
, pp. 1349-1358
-
-
Uzcudun, A.E.1
Batlle, J.F.2
Velasco, J.C.3
Sanchez Santos, M.E.4
Carpeno Jde, C.5
Grande, A.G.6
Juberias, A.M.7
Pineiro, E.H.8
Olivar, L.M.9
Garcia, A.G.10
-
21
-
-
4143132330
-
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up
-
Fernandez-Martos C, Aparicio J, Bosch C, Torregrosa M, Campos JM, Garcera S, Vincent JM, Maestu I, Climent MA, Mengual JL, Tormo A, Hernandez A, Estevan R, Richart JM, Viciano V, Uribe N, Campos J, Puchades R, Arlandis F and Almenar D: Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-up. J Clin Oncol 22: 3016-3022, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3016-3022
-
-
Fernandez-Martos, C.1
Aparicio, J.2
Bosch, C.3
Torregrosa, M.4
Campos, J.M.5
Garcera, S.6
Vincent, J.M.7
Maestu, I.8
Climent, M.A.9
Mengual, J.L.10
Tormo, A.11
Hernandez, A.12
Estevan, R.13
Richart, J.M.14
Viciano, V.15
Uribe, N.16
Campos, J.17
Puchades, R.18
Arlandis, F.19
Almenar, D.20
more..
-
22
-
-
20044396718
-
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer
-
Wang LW, Yang SH, Lin JK, Lin TC, Chan WK, Chen WS, Wang HS, Jiang JK, Lee RC, Li AF, Chao Y, Chi KH and Yen SH: Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol 89: 256-263, 2005.
-
(2005)
J Surg Oncol
, vol.89
, pp. 256-263
-
-
Wang, L.W.1
Yang, S.H.2
Lin, J.K.3
Lin, T.C.4
Chan, W.K.5
Chen, W.S.6
Wang, H.S.7
Jiang, J.K.8
Lee, R.C.9
Li, A.F.10
Chao, Y.11
Chi, K.H.12
Yen, S.H.13
|